SCHEMBL13413389

SCHEMBL13413389

CC(C)(C)OC(=O)n1cnc2cc(F)c(Cn3c4cc(F)c5ccoc5c4c4c5cccnc5oc(=O)c43)cc2c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13395636 0.90 — —
SCHEMBL12624071 0.87 — —
SCHEMBL12388862 0.87 — —
SCHEMBL12623877 0.87 ACVR1 (0.33) —
SCHEMBL12624098 0.86 — —
SCHEMBL12624066 0.86 — —
SCHEMBL14154802 0.86 — —
SCHEMBL12624060 0.85 PDPK1 (0.32) —
SCHEMBL12624029 0.85 PARP1 (0.30) —
SCHEMBL12623999 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8557848-B2 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections MERCK SHARP & DOHME CORP. (US) 2013-10-15 — — US disclosed
US-20100098661-A1 4,5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS SCHERING CORPORATION 2010-04-22 — — US disclosed
Send feedback